Erste Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Erste Asset Management’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,500	Closed	-$1.31M	–	518
2020 Q4	$1.31M	Sell	10,500 -3,100	-23%	-$274K	0.04%	312
2020 Q3	$681K	Hold	13,600	–	–	0.02%	330
2020 Q2	$610K	Hold	13,600	–	–	0.02%	330
2020 Q1	$665K	Hold	13,600	–	–	0.04%	285
2019 Q4	$797K	Buy	+13,600	New	+$673K	0.04%	295

Erste Asset Management's EIDX Position: Q1 2021 in Review

Erste Asset Management sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 10,500 shares — an estimated $1.31M sold.

Erste Asset Management first reported a position in EIDX in Q4 2019 and held it in 5 quarters. The position peaked at $1.31M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

Erste Asset Management reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Erste Asset Management sold 10,500 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $1.31M.
Erste Asset Management first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
Erste Asset Management's Eidos Therapeutics, Inc. Common Stock position peaked at $1.31M in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Erste Asset Management's 13F filing for Q1 2021, filed 25 Nov 2024.